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888Objective: To evaluate our extensive clinical experience using deep hypothermic circulatory arrest (DHCA) as a
sole method of cerebral protection during aortic arch surgery, with an emphasis on determining the safe duration
of DHCA.
Methods: A total of 490 consecutive patients (303 males [61.8%], mean age, 62.7  13.5 years) underwent
surgical interventions on the aortic arch with straight DHCA for cerebral protection. Of the procedures,
65 (13.3%) were either urgent or emergency. Aortic aneurysms (n ¼ 417, 85.1%) and dissections (n ¼ 71,
14.5%) were the main indications for surgery.
Results: The mean DHCA duration was 29.2  7.9 minutes at a mean bladder temperature of 18.7C. The
overall mortality was 2.4% (12 of 490), and elective mortality was 1.4% (6 of 425). The seizure rate was
1.4% (7 of 490). Six patients (1.2%) developed renal failure that required dialysis. The postoperative stroke
rate was 1.6% (8 of 490) and was 1.2% (5 of 425) for the elective cases. The overall stroke rate for patients
requiring<50 minutes of DHCAwas 1.3% (6 of 478), significantly different from the 16.7% (2 of 12) stroke
rate for patients requiring>50 minutes of DHCA (P ¼ .014). Multivariate analysis revealed a DHCA time
>50 minutes (odds ratio, 5.11  4.01, P ¼ .038) and aortic dissection (odds ratio, 3.59  1.72, P ¼ .008)
to be strong predictors of composite adverse outcomes.
Conclusions: Straight DHCA is a safe and effective technique of cerebral protection for the absolute majority of
interventions involving the aortic arch. At experienced centers, up to 50minutes of DHCA can be considered safe,
without significant postoperativemortality or neurologic sequelae. (J Thorac Cardiovasc Surg 2014;148:888-900)De Bakey and colleagues1,2 performed the first successful
surgical arch replacement procedure and subsequently
reported a mortality rate of 42% for the first series of arch
replacements. Since those early days, the focus of research
in this area has aimed at improving surgical techniques
and methods of cerebral protection. Cerebral protection
has always been a cornerstone of successful arch surgery,
although to date, no consensus has been reached regarding
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The Journal of Thoracic and Cardiovascular SurgHistorically, hypothermia was the first method of cerebral
protection that was used in arch surgery. Initially proven
effective for cardiac procedures by Meshalkin in Siberia in
the 1950s,6 deep hypothermic circulatory arrest (DHCA)
was introduced into clinical practice for aortic arch surgery
by Griepp and associates.7,8
Hypothermia provides neuroprotection by significantly
decreasing the global cerebral metabolic rate for glucose
and oxygen.9 Hypothermia also significantly reduces
temperature-dependent release and extracellular levels of
excitatory neurotransmitters such as glutamate, inhibits
the pro-apoptotic activity, and reduces the levels of free
radicals and inflammatory cytokines.10
Clinically, Svensson and colleagues11 showed DHCA to
be safe and effective for aortic arch surgery in a large
patient series. Our group previously reported the safety
and effectiveness of DHCA in a series that included
both ascending/arch and descending/thoracoabdominal
procedures.12 More recently, however, with the increasing
popularity of adjunctive cerebral perfusion strategies
(ie, antegrade [ACP] and retrograde cerebral perfusion
[RCP]), the safety and effectiveness of straight DHCA as
the sole method of cerebral protection for surgery of the
aortic arch has been questioned.13,14 In particular, the
question regarding the DHCA duration that can be
considered safe has been debated. Several published
reports have suggested that a DHCA time of>20 to 25ery c September 2014
Abbreviations and Acronyms
ACP ¼ antegrade cerebral perfusion
CPB ¼ cardiopulmonary bypass
DHCA ¼ deep hypothermic circulatory arrest
OR ¼ odds ratio
RCP ¼ retrograde cerebral perfusion
Ziganshin et al Acquired Cardiovascular Diseaseminutes will result in adverse outcomes and poor quality of
life postoperatively in patients undergoing thoracic aortic
surgery.15,16 However, this is not in line with our
experience using DHCA. Therefore, the aim of the
present study was to evaluate our extensive experience
using DHCA as a sole means of cerebral protection
during surgery of the aortic arch, with an emphasis on
determining the safe duration of DHCA. We found that
straight DHCA is a safe and effective technique of
cerebral protection for the absolute majority of
interventions involving the aortic arch that can be
performed within a safe 50 minutes of DHCA.A
C
DMETHODS
Patient Profile
During the previous 11-year period, from January 2003 until September
2013, 490 consecutive patients (mean age, 62.7  13.5 years, 303 males,
187 females) underwent surgical interventions on the aortic arch by a single
surgeon at Yale-New Haven Hospital (New Haven, Conn). In all 490 cases,
straightDHCAwasthe solemethodof cerebral protection; noadjunct perfusion
techniques were used. These patients were included in the present study, and a
detailed retrospectivemedical record analysis of these patients was performed.
The preoperative characteristics are presented in Table 1. The indications
for surgery included aortic aneurysm in 417 (85.1%), aortic dissection in 71
(14.5%),which includedacute aortic syndromes (penetrating aortic ulcer and
intramural hematoma), and atheroma of the aortic arch in 2 (0.4%). Of the
procedures, 65 (13.3%)wereeitherurgent or emergency; all other procedures
were performedelectively. Seventy-one patients (14.5%) had undergone pre-
vious cardiac surgery, including 3 patients (0.6%) with previous heart trans-
plants. Sixty-five patients (13.3%) had undergone previous aortic surgery,
involving the aortic valve (n ¼ 42, 8.6%), ascending aorta (n ¼ 28, 5.7%),
aortic arch (n ¼ 2, 0.4%), descending or thoracoabdominal aorta (n ¼ 6,
1.2%), or abdominal aorta (n ¼ 2, 0.4%; multiple previous sites in some
cases). The extent of surgical intervention included replacement of the
ascending aorta and hemiarch in 392 patients (80.0%), replacement of the
ascending aorta and total arch in 74 (14.5%), total replacement of the aortic
arch in 13 (2.7%), and repair of the aortic arch in 11 patients (2.2%).
DHCATechnique
Our preferred technique of conducting DHCA has been previously
described in detail.6,12,17 The main points are as follows:
1. Establishment of cardiopulmonary bypass (CPB): the femoral artery is our
preferred site for arterial cannulation to establish CPB during
interventions on the ascending aorta and aortic arch (technique described
previously18). Femoral cannulation was used in 390 patients (79.6%). In
cases in which arteriosclerotic disease of the descending aorta was noted
by intraoperative transesophageal echocardiography or preoperative
computed tomography (routinely performed for patients undergoing
elective surgery), we used axillary cannulation (n ¼ 49, 10.0%), directThe Journal of Thoracic and Cacannulation of the ascending aorta/aortic arch (n ¼ 46, 9.4%), or
cannulation of the innominate artery (n ¼ 5, 1.0%). Venous return was
achieved via the right atrial appendage using a 2-stage cannula
(n¼ 485, 99.0%) or, in rare cases, via the femoral vein (n¼ 5, 1.0%).
2. Topical cooling: the patient’s head is packed in ice to achieve topical cool-
ing from the start of the procedure until the end of the circulatory arrest.
3. Systemic cooling: after initiation of CPB, the patient is cooled down to
20C (for hemiarch procedures) or 18C (for total arch replacements).
Cooling to the target temperatures require about 30 to 40 minutes,
depending on the patient’s size.
4. Temperature monitoring: temperature monitoring is conducted solely
via a probe in the urinary bladder.
5. Anesthetic considerations: steroids are routinely administered for all
patients before CPB is initiated. Alpha-stat management is used
routinely to maintain the acid-base balance.
6. Rewarming: once circulatory arrest has been terminated, rewarming is
initiated, requiring approximately 60 minutes (also dependent on
patient size). We prefer gentle rewarming (gradient between blood
and bath temperature of <10C) to prevent potential protein
denaturation. Rewarming is taken to a temperature of 34 to 36C.DHCA Duration
The mean DHCA duration was 29.2  7.9 minutes at a mean
bladder temperature of 18.7C. Of the 490 patients, 61 (12.4%) required
a DHCA time of >40 minutes; only 12 patients (2.4%) required
50 minutes (Figure 1 shows the DHCA time distribution).
Operative Technique
All surgical interventions were performed through a standard median
sternotomy with the use of CPB and DHCA. Detailed operative data are
presented in Table 2. Carbon dioxide flooding of the surgical field was
used in all cases. The extent of surgical resection depends on the disease
extent to excise all severely dilated segments of the aorta. Once the patient
has been cooled and circulatory arrest initiated, the aorta is unclamped and
distal anastomosis performed. In patients requiring total arch replacement,
the distal anastomosis is performed at the level of the proximal descending
aorta or at the level just before take off of the left subclavian artery. In most
cases, this was combined with the elephant trunk procedure. The arch
vessels were then reconstructed, either using the ‘‘island’’ technique or
by anastomosing each branch with individual grafts. Our preferred
technique has been to use a 2-vessel patch (including the innominate artery
and left common carotid artery), which is anastomosed to the main graft
(Figure 2, B). The left subclavian artery is reconstructed at a later stage,
often during the rewarming period or after CPB termination.Definitions of Early Mortality, Stroke, and Adverse
Outcomes
Early mortality was defined as a death that occurred within the first
30 days postoperatively or before discharge from the hospital.
Stroke was defined as a recognized neurologic deficit documented
clinically and radiologically (computed tomography or magnetic
resonance imaging). Temporary neurologic disturbances that were not
proved by imaging studies were not classified as a stroke. All strokes
were classified as either embolic in nature or hypoperfusion related.
Several unfavorable outcomes of surgical treatment that could have
been related to DHCA were classified as adverse outcomes, and all were
analyzed together. These included early mortality, postoperative stroke,
seizures, and acute renal failure.
Long-Term Follow-up
Long-term postoperative follow-up of the patients was conducted
through our Aortic Institute Database and clinical visits, patient interviews,rdiovascular Surgery c Volume 148, Number 3 889
TABLE 1. Patient preoperative characteristics
Variable Overall No adverse outcomes* Adverse outcomes* P value
Total patients 490 (100) 467 (95.3) 23 (4.7) —
Male sex 303 (61.8) 291 (62.3) 11 (47.8) .328
Age (y)
Mean  SD 62.7  13.5 62.6  13.3 65.6  18.4 .303
Range 14-88 24-88 14-82
Comorbidities and risk factors
Hypertension 343 (70.0) 328 (70.2) 15 (65.2) .610
Tobacco smoking 216 (44.1) 204 (43.7) 12 (52.2) .424
Dyslipidemia 208 (42.4) 196 (42.0) 12 (52.2) .335
Coronary artery disease 91 (12.4) 78 (16.7) 13 (56.5) <.001y
Pulmonary or respiratory disease 58 (11.8) 54 (11.6) 4 (17.4) .398
Neurologic deficit 41 (8.4) 36 (7.7) 5 (21.7) .018y
Chronic kidney disease 38 (7.8) 33 (7.1) 5 (21.7) .010y
Preoperative atrial fibrillation 37 (7.6) 35 (7.5) 2 (8.7) .831
Diabetes 32 (6.5) 30 (6.4) 2 (8.7) .669
Peripheral vascular disease 18 (3.7) 14 (3.0) 4 (17.4) <.001y
Marfan syndrome 9 (1.8) 9 (1.9) 0 (0.0) .501
Hyperthyroidism 3 (0.6) 3 (0.6) 0 (0.0) .700
Hypothyroidism 3 (0.6) 3 (0.6) 0 (0.0) .700
Positive family history 111 (22.7) 104 (22.3) 7 (30.4) .362
Previous cardiac surgery 71 (14.5) 63 (13.5) 8 (34.8) .005y
Previous aortic surgery 65 (13.3) 59 (12.6) 6 (26.1) .063
Native aortic valve morphology (n ¼ 447)
Tricuspid 329 (73.6) 313 (73.0) 16 (88.9) .176
Bicuspid 117 (26.2) 115 (26.8) 2 (11.1) .176
Unicuspid 1 (0.2) 1 (0.2) 0 (0.0) 1.0
Data presented as n (%), unless noted otherwise. SD, Standard deviation. *Adverse outcomes included early mortality, stroke, seizures, and acute renal failure. yStatistically
significant.
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490 of the patients (100%). The mean follow-up period was 60.9  38.5
months.
Statistical Analysis
Statistical analysis was performed as described recently by Rizzo et al.19
Pearson’s chi-square test and Fisher’s exact test were used to compare
proportions (categorical variables). The 2-tailed unpaired t test was usedFIGURE 1. Distribution of deep hypothermic circulatory arrest (DHCA)
time among 490 patients.
890 The Journal of Thoracic and Cardiovascular Surgto compare continuous variables. Bivariate analysis and multivariable
logistic regression analysis were used to identify the predictors of adverse
outcomes and was performed using Statistical Analysis Systems software
(SAS Institute Inc, Cary, NC). Because of a low number of unfavorable
outcomes, the multivariable analysis was able to accommodate only
3 predictor variables for the adverse outcomes analysis and 2 predictor
variables for the early mortality analysis (to avoid overfitting). The
Kaplan-Meier actuarial method was used to estimate long-term survival.
RESULTS
Early Mortality
Of the 490 patients, 12 (2.4%) died within the first
30 days of the surgical intervention. Detailed information
on all early deaths is listed in Table 3. Of these patients,
4 (33.3%) had undergone a previous cardiac procedure,
7 (58.3%) had developed aortic dissection, and 6 (50.0%)
underwent either urgent or emergency surgery (multiple
categories for some patients). The duration of DHCA in
this group of patients ranged from 26 to 50 minutes
(mean, 34.6  6.9). Four patients (33.3%) experienced a
stroke, 1 of which was related to cold agglutinin disease
that had not been recognized preoperatively.
The early mortality among the patients operated
electively was 1.4% (6 of 425). Five of these patients
had been treated for an aortic aneurysm, and one had
had chronic aortic dissection. One patient developed anery c September 2014
TABLE 2. Operative data
Variable Overall No adverse outcomes* Adverse outcomes* P value
Total patients 490 (100) 467 (95.3) 23 (4.7) —
Emergency or urgent procedures 65 (13.3) 56 (12.0) 9 (39.1) <.001y
Primary indication for surgery (diagnosis)
Aneurysm 417 (85.1) 403 (86.3) 14 (60.9) .001y
Dissection 71 (14.5) 62 (13.3) 9 (39.1) .001y
CPB time (min)
Mean  SD 157.1  34.6 155.2  31.8 197.6  58.3 <.001y
Range 82-349 82-302 133-349 —
Aortic crossclamp time (min)
Mean  SD 85.5  31.8 85.1  32.0 97.3  25.1 .080
Range 4-176 4-176 42-140 —
DHCA
Bladder temperature (C)
Mean  SD 18.7  0.7 18.7  0.7 18.1  0.8 <.001y
Range 16-22 16-22 16-20 —
DHCA duration (min)
Mean  SD 29.2  7.9 28.9  7.6 36.3  10.2 <.001y
Range 10-62 10-54 19-62 —
Types of arch vessel anastomosis (n ¼ 87)
Two-vessel island 57 (65.6) 53 (66.3) 4 (57.1) .688
Three-vessel island 1 (1.1) 1 (1.3) 0 (0.0) 1.0
Branched arch graft or individual grafts to each vessel 29 (33.3) 26 (32.5) 3 (42.9) .681
Associated cardiac procedures
Aortic valve replacement 282 (57.6) 271 (58.0) 11 (47.8) .335
Mechanical 168 (34.3) 161 (34.5) 7 (30.4) .689
Biologic (bioprosthesis) 114 (23.3) 110 (23.6) 4 (17.4) .493
Aortic valve repair 4 (0.8) 3 (0.6) 1 (4.3) .175
Aortic root replacement (composite graft) 124 (25.3) 121 (25.9) 3 (13.0) .166
Coronary artery bypass grafting 72 (14.7) 63 (13.5) 9 (39.1) .001y
Elephant trunk implantation 55 (11.2) 52 (11.1) 3 (13.0) .777
Permanent pacemaker implantation 28 (5.7) 28 (6.0) 0 (0.0) .227
Coronary interposition graft (modified Cabrol technique) 18 (3.7) 16 (3.4) 2 (8.7) .190
Left atrial appendage ligation 11 (2.2) 11 (2.4) 0 (0.0) .457
Innominate artery reconstruction 7 (1.4) 6 (1.3) 1 (4.3) .227
Intra-aortic balloon pump placement 6 (1.2) 1 (0.2) 5 (21.7) <.001y
Pericardial shunt with right atrium (Cabrol shunt) 4 (0.8) 3 (0.6) 1 (4.3) .054
Atrial septal defect closure 4 (0.8) 4 (0.9) 0 (0.0) .656
Mitral valve replacement 3 (0.6) 3 (0.6) 0 (0.0) .700
Left ventricular assist device insertion 2 (0.4) 1 (0.2) 1 (4.3) .002y
Data presented as n (%), unless noted otherwise. CPB, Cardiopulmonary bypass; SD, standard deviation; DHCA, deep hypothermic circulatory arrest. *Adverse outcomes
included early mortality, stroke, seizures, and acute renal failure. yStatistically significant.
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Dintraoperative type A dissection and subsequently
experienced a stroke. Another patient required placement
of a left ventricular assist device during aortic arch
intervention, had a difficult postoperative course, and died
during a second procedure (during the same hospitalization)
for left ventricular assist device replacement.
Early Morbidity
The postoperative complications and their incidence are
listed in Table 4. Atrial fibrillation was the most common
postoperative complication, seen in 196 patients (40.0%).
However, at discharge from the hospital, atrial fibrillation
persisted in only 54 patients (11.0%). Re-exploration forThe Journal of Thoracic and Cableeding was required in 22 patients (4.5%). Seven patients
developed seizures (1.4%), and 6 (1.2%) developed acute
renal failure and required either dialysis or continuous
venovenous hemofiltration.
Postoperative Stroke Rate
The overall postoperative stroke rate was 1.6% (8 of
490). Four of these patients (50.0%) died during the first
30 days after the surgical intervention. Brain imaging in
all patients with stroke was reviewed with a neuroradiolo-
gist. In 5 patients (62.5%), the nature of the stroke was
determined to be of embolic origin; the other 3 patients
(37.5%) had had a hypoperfusion-related stroke. Amongrdiovascular Surgery c Volume 148, Number 3 891
FIGURE 2. Techniques for aortic arch replacement. A, The 3-vessel Carrel patch technique. B, The 2-vessel Carrel patch technique, preferred at our
institution.
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Dthe 5 patients who had developed embolic strokes, 2 had
received retrograde arterial perfusion via the femoral
artery (40%), and 3 had received antegrade arterial
perfusion via the distal aortic arch (n ¼ 2, 40%) and
right axillary artery (n ¼ 1, 20%). The mean DHCA period
among the patients who had experienced a stroke was
38.8  12.5 minutes (range, 26-62). Stroke occurred in
only 5 patients (1.2%) who had undergone elective
surgical treatment.
Three of the patients (37.5%) with a postoperative stroke
had had pre-existing neurologic conditions (previous
strokes in 2 patients, 1 of whom had undergone previous
carotid endarterectomy, 1 patient with speech problems
after a Chiari malformation correction procedure). Three
patients (37.5%) had undergone previous cardiac
interventions. One patient who developed a stroke was a
14-year-old male adolescent, with a history of heart
transplantation at 2 months old for hypoplastic left heart
syndrome, and later developed a major enlargement of the
aortic arch in the native aortic region.
Relationship of Stroke and DHCA Duration
To determine the effect of the DHCA duration on
the postoperative neurologic status, the patients were
subdivided into 5 groups according to the DHCA time:
0 to 19 minutes in 21, 20 to 29 minutes in 277, 30 to 39
minutes in 131, 40 to 49 minutes in 49, and 50 minutes
in 12. The stroke rate was determined for each group
separately. The relationship between the stroke rate and
the DHCA duration is presented in Figure 3. The stroke
rate in the 40- to 49-minute group was 2.0% (1 of 49),
which was not significantly different from the stroke rate892 The Journal of Thoracic and Cardiovascular Surg(1.2%, 5 of 429) for patients requiring <40 minutes
(P ¼ .48). The overall stroke rate for patients requiring
<50 minutes of DHCA was 1.3% (6 of 478), significantly
different from the 16.7% (2 of 12) stroke rate in patients
requiring 50 minutes of DHCA (P ¼ .014). In the
patients with 50 minutes of DHCA, the cases of the 2
patients with cerebral events were extremely complex.
One had undergone heart transplantation previously, was
unstable hemodynamically perioperatively, and manifested
diffuse hypoperfusion encephalopathy. The other patient
developed an intraoperative aortic dissection during
elective replacement surgery for aneurysm of the ascending
aorta and total arch and experienced an embolic stroke. The
brain events in these 2 patients might not have been related
to the methods of brain protection. All 10 other patients
with 50 minutes DHCA experienced no cerebral events
whatsoever.
Bivariate and Multivariable Predictors of Adverse
Outcomes
Adverse outcomes were defined as the occurrence of
early mortality (n ¼ 12, 2.4%), stroke (n ¼ 8, 1.6%),
seizures (n ¼ 7, 1.4%), and acute renal failure (n ¼ 6,
1.2%). The total number of patients who experienced any
of these adverse outcomes was 23 (4.7%). The results of
bivariate analysis are presented in Tables 1 and 2.
Bivariate analysis showed the presence of coronary artery
disease (P < .001), a pre-existing neurologic deficit
(P ¼ .018), chronic kidney disease (P ¼ .010), peripheral
vascular disease (P< .001), and previous cardiac surgery
(P ¼ .005) to be preoperative, pre-existing predictors of
adverse outcomes. The rate of previous aortic surgery wasery c September 2014
TABLE 3. Cause of early death
Pt.
no.
Age
(y) Sex Comorbidities
Reope-
ration
Surgical
acuity
Primary
diagnosis
Hemiarch
or total
arch
Concomitant
procedures
DHCA
time
(min)
Postoperative
stroke Cause of death
1 57 M HTN, DL, smoking, CKD
(kidney transplant 17 y
ago), CAD (CABG34
9 y earlier)
Yes Elective Dissection Hemiarch AVR,
interposition
graft to LCA,
LVAD
31 No LV failure
(intraoperatively
during second
procedure for LVAD
replacement)
2 68 F HTN, DM, smoking,
COPD, CAD (PTCA
1 y earlier)
No Emergency Dissection Hemiarch — 38 Yes Multiple cerebral
infarcts (embolic),
thromboembolic
events to lower
extremities,
multiorgan failure
3 76 M DL, CAD (post-MI,
CABG33 24 y earlier)
Yes Emergency Dissection Hemiarch — 32 Yes Cold agglutinin
disease, multiple
cerebral infarcts
4 58 F Smoking, 5 mo before
type B dissection and
thoracoabdominal
fenestration procedure
No Emergency Dissection Hemiarch AV repair, shunt
to RA, IABP
39 No Malignant ventricular
arrhythmia 9 d
postoperatively
5 70 M HTN, DL, smoking, CAD,
AF (warfarin)
No Emergency Dissection Hemiarch AVR
(composite),
CABG31
32 No Intraoperative death,
acute heart failure
6 77 F HTN, DL, neurologic
deficit (stroke, CAE
3 y earlier), COPD
No Elective Aneurysm Total arch AVR, CABG31 26 Yes Multiple cerebral
infarcts (embolic)
7 81 M HTN, DL, CKD, CAD,
arch branching anomaly
(bovine arch)
No Elective Aneurysm Hemiarch AVR, CABG33 30 No Acute renal failure,
pulmonary edema
8 61 M HTN, DL, DM, smoking,
CKD, neurologic deficit
(strokes with right-sided
deficit, TIAs)
No Emergency Dissection Total arch AVR, ET,
innominate
reconstruction
44 No Ventricular arrhythmia
3 d postoperatively
during PV procedure
for ischemic limb
9 67 F HTN No Elective Aneurysm Hemiarch AVR 28 No Ventricular tachycardia
and cardiac arrest
5 d postoperatively
10 82 M HTN, smoking, CAD
(CABG32 and AVR
16 y earlier), occluded
vein graft to CMA, TI
Yes Elective Aneurysm Hemiarch Interposition
graft to RCA,
IABP
32 No Ventricular arrhythmia
(pre-existing)
11 69 F HTN, smoking, arch
branching anomaly
(bovine arch)
No Elective Aneurysm Total arch — 50 Yes Intraoperative type A
dissection, cerebral
infarct (embolic)
12 80 F HTN, smoking, CAD,
status: after type A
dissection 10 y earlier
with ascending aortic
replacement
Yes Urgent Dissection Hemiarch AVR, CABG32,
IABP
33 No Right ventricular
failure, acute
respiratory failure
Pt. no., Patient number;DHCA, deep hypothermic circulatory arrest;M, male;HTN, hypertension;DL, dyslipidemia;CKD, chronic kidney disease;CAD, coronary artery disease;
CABG, coronary artery bypass grafting; AVR, aortic valve replacement; LCA, left coronary artery; LVAD, left ventricular assist device; F, female; DM, diabetes mellitus; COPD,
chronic obstructive pulmonary disease; PTCA, percutaneous transluminal coronary angioplasty;MI, myocardial infarction; AV, aortic valve; RA, right atrium; IABP, intra-aortic
balloon pump; AF, atrial fibrillation; CAE, carotid endarterectomy; TIA, transient ischemic attack; ET, elephant trunk; PV, peripheral vascular; CMA, circumflex marginal artery;
TI, tricuspid insufficiency; RCA, right coronary artery.
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TABLE 4. Postoperative complications
Variable n (%)
Atrial fibrillation 196 (40.0)
Pulmonary complications (parenchymal) 27 (5.5)
Prolonged ventilation (>48 h) 23 (4.7)
Reexploration for bleeding 22 (4.5)
Other arrhythmias 18 (3.7)
Pleural complications (pneumothorax/effusion) 12 (2.4)
Stroke 8 (1.6)
Wound complications 7 (1.4)
Seizures 7 (1.4)
Acute renal failure requiring dialysis or CVVH 6 (1.2)
Pericardial effusion 5 (1.0)
Pacemaker implantation 4 (0.8)
Percutaneous endoscopic gastrostomy tube placement 4 (0.8)
Tracheostomy 3 (0.6)
Venous thromboembolism 3 (0.6)
Systemic infections 2 (0.4)
Low cardiac output 2 (0.4)
Postoperative intra-aortic balloon pump placement 1 (0.2)
Myocardial ischemia 1 (0.2)
Mesenteric hemorrhage 1 (0.2)
CVVH, Continuous venovenous hemofiltration.
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in no adverse outcomes group (12.6%), although no
significant difference was observed. In terms of the
operative data, aortic dissection as the primary diagnosis
and indication for surgery (P ¼ .001), an urgent orFIGURE 3. Relationship between postoperative stroke rates and deep hypoth
number of patients in each DHCA time category is indicted. Note that the co
with extremely complex cases) among only 12 patients with DHCA of this dur
894 The Journal of Thoracic and Cardiovascular Surgemergency surgical intervention (P< .001), concomitant
coronary artery bypass grafting (P ¼ .001), CPB duration
(P < .001), and DHCA duration (P < .001) were also
predictors of adverse outcomes.
Multivariable analysis was used to determine the
predictors of adverse outcomes (Table 5) and showed
that the extent of surgery (hemiarch vs total arch
replacement) was not a predictor of adverse outcomes
(odds ratio [OR], 1.11  0.60; P ¼ .844). However, aortic
dissection as the primary indication for surgery (OR, 3.59
 1.72; P ¼ .008) and DHCA duration of>50 minutes
(OR, 5.11  4.01; P ¼ .038) were predictors of adverse
outcomes.
Multivariable analysis was also used to determine
the predictors of early mortality (Table 5). Again, the
extent of surgery was not a predictor of mortality
(OR, 0.67  0.48; P ¼ .580); however, aortic dissection
as the indication for surgery was a strong predictor of early
mortality (OR, 14.58  9.48; P<.001).
Long-Term Survival
Long-term postoperative follow-up of hospital survivors
revealed that 75 patients (15.7%) had died late (excluding
the early deaths), having lived an average of 41.7  34.4
months (range, 1-130) postoperatively before death, and
403 patients (84.3%) were still alive. The actuarial
survival for patients who had undergone aortic arch
surgery with DHCAwas 93.2%  1.1%, 89.4%  1.4%,ermic circulatory arrest (DHCA) duration during aortic arch surgery. The
lumn for ‘‘50 and over’’ was determined from only 2 strokes (in patients
ation. See text for details.
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TABLE 5. Multivariate analysis of predictors of adverse outcomes
and early mortality
Variable OR ± SE 95% CI
P
value
Risk of developing an adverse outcome
Extent of surgery (total arch
vs hemiarch replacement)
1.11  0.60 0.38-3.22 .844
DHCA duration>50 min 5.11  4.01 1.10-23.80 .038*
Dissection as primary indication
for surgery
3.59  1.72 1.40-9.17 .008*
Risk of early mortality
Extent of surgery (total arch
vs hemiarch replacement)
0.67  0.48 0.16-2.76 .580
Dissection as primary indication
for surgery
14.58  9.48 4.07-52.18<.001*
OR, Odds ratio; SE, standard error;CI, confidence interval;DHCA, deep hypothermic
circulatory arrest. *Statistically significant.
Ziganshin et al Acquired Cardiovascular Disease84.8% 1.8%, and 72.1% 3.6% at 1, 3, 5, and 10 years,
respectively (Figure 4).A
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DDISCUSSION
In the present study, we have shown that DHCA is a safe
and effective technique for neuroprotection during surgery
of the aortic arch. At our institution, we have accumulated
significant experience with straight DHCA during the past
25 years, and we believe that almost all arch replacements
can be performed safely with DHCA. Our results also
provide evidence that at experienced centers up to 50
minutes of circulatory arrest under hypothermic conditions
can be considered safe, although we have found that most
arch operations can be performed within 40 minutes.FIGURE 4. Kaplan-Meier survival curve for patients rec
The Journal of Thoracic and CaTwo-Vessel Island Technique for Arch Vessel
Reimplantation
Over the years, several techniques for reimplantation of
the great vessels have evolved, including the 3-vessel Carrel
patch20 (Figure 2, A), 3-branched grafts,21,22 4-branched
grafts,23 and, most recently, the hybrid 4-branched graft
combined with a stent graft at the distal end.24
Our preferred technique for arch vessel reimplantation
has used a 2-vessel Carrel patch that includes just the
innominate artery and left common carotid artery
(Figure 2, B). The advantages of using the 2-vessel patch
are the reduction in the length of the anastomosis line,
enabling the surgeon to complete the head-vessel
anastomosis within a shorter period, and complete access
in case additional hemostatic sutures are necessary for the
pedicle or distal elephant trunk anastomosis. The left
subclavian artery is reanastomosed at a later stage in the
procedure, usually during the rewarming period. It can
also be replaced at a later second-stage elephant trunk
procedure through a left thoracotomy.
In the present patient series, the 2-vessel island technique
was used in 65.6% of total arch replacement cases. How-
ever, sometimes using a 2-vessel patch is not feasible, for
example cases in which either the innominate or left
common carotid artery is aneurysmal or severely dissected
or in which a risk of repeat dissection or embolization from
atherosclerotic or calcium debris exists. In these cases, we
have used one of the multibranch techniques to reattach
the head vessels; however, even this more complex proce-
dure can be accomplished within 40 minutes of DHCA.
In most cases, we will also supplement the arch
replacement procedure with implantation of the elephanteiving deep hypothermic circulatory arrest (DHCA).
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Dtrunk graft (performed in 63.2% of all total arch
replacements). This has proved extremely useful should a
second-stage procedure involving the descending aorta
(open or endovascular) be needed. Traditionally, the distal
arch anastomosis with the elephant trunk graft is created
distal to the take off of the left subclavian artery. However,
recently, we have started creating the distal anastomosis
between the origins of the left common carotid and left
subclavian arteries. This approach provides better access
to the suture lines, should inspection for the purpose of
hemostasis be required at anastomosis completion. With
the traditional approach, access to the distal suture line in
the case of bleeding can be impossible.
Early Mortality and Morbidity
The present study revealed low levels of early mortality
and morbidity in patients undergoing surgery under
DHCA. The overall mortality in our series was 2.4%, and
the elective mortality was 1.4%. This is comparable with
our previously reported results in an earlier, smaller se-
ries.12 We studied all 12 patients who had died within the
first 30 days of the surgical intervention in great detail to
determine the cause of death (Table 3). It appears that
only 4 of the 12 deaths (33%) were brain related and could
potentially be associated with the method of cerebral
protection. Other deaths occurred for reasons that were
most likely not related to the method of brain protection.
Multivariate analysis revealed aortic dissection to be a
strong predictor of early mortality. The most recent
large-scale studies that evaluated other cerebral protection
techniques have reported mortality levels to be in the range
of 3.2% to 11.6% for ACP and 4.1% to 17.0% for RCP
(a detailed review of the data can be found in Chau and
colleagues17 and Ziganshin and Elefteriades25). The present
results with straight DHCA compared very favorably with
these reports for ACP and RCP.
The overall postoperative stroke rate in our study was
1.6%, and for the elective cases was 1.2%. Of the 8
strokes, 5 (62.5%) were embolic in nature and 3 were
related to hypoperfusion. This echoes the findings of our
previous study.12 That approximately two thirds of the
strokes were embolic suggests that they were most likely
not related to any inadequacy of DHCA as a cerebral
protection strategy; rather, the occurrence of embolic
strokes represented the severity of the underlying
arteriosclerotic disease in these patients. The same large-
scale studies that reported the mortality rates for patients
undergoing aortic arch surgery with adjunctive perfusion
techniques also reported the postoperative stroke rate:
2.2% to 9.6% for ACP and 2.9% to 9.0% for RCP.17,25
Comparing our postoperative mortality and stroke rates
with these results, we have concluded that straight
DHCA is not inferior to other neuroprotection strategies
that rely on perfusion adjuncts.896 The Journal of Thoracic and Cardiovascular SurgAn analysis of the potential DHCA-related postoperative
complications (early mortality, postoperative stroke, sei-
zures, and acute renal failure) showed that these adverse
outcomes tended to develop in patients with significant
pre-existing comorbidities or who had required emergency
surgery. In our study, these patients had significantly greater
rates of neurologic comorbidities, coronary artery disease,
chronic kidney disease, and peripheral vascular disease
(Table 1) and required more complex surgical interventions
(Table 2). Also, the patients were much more likely to
develop adverse outcomes if they had previously undergone
open heart surgery.
These findings are suggestive that the adverse outcomes
in these patients were most likely not from an inadequacy
of DHCA as a neuroprotector, but rather resulted from the
complexity of the surgical procedure and the severity of
the underlying conditions, which would increase the risk
of any surgical intervention, even without DHCA.
Safe DHCA Duration
There is no consensus in the literature in terms of the
duration of DHCA that can be considered safe. In an early
report, Svensson and colleagues11 showed that the
incidence of postoperative stroke increased in cases that
required>40 minutes of DHCA. Another study showed
that as long as 60 minutes of DHCA could be considered
safe.26 More recent publications, however, have argued
that only 20 to 25 minutes of DHCA can be considered
safe.16,27,28 In our previous report, we identified 40
minutes as the cutoff point, beyond which caution would
be warranted.12
In the present study, to determine the DHCA duration that
can be considered safe from the neuroprotective standpoint,
we analyzed the occurrence of stroke in relationship to the
DHCA duration (Figure 3). We found that the stroke rate
increased significantly in patients with a DHCA duration
50 minutes (16.7%). In the patients with a DHCA period
of 40 to 49 minutes, the stroke rate was 2.0%. This finding
was also supported by the results of multivariable analysis
that determined that DHCA times 50 minutes to be
significant predictors of early mortality and adverse
outcomes (Table 5). However, the stroke rate in patients
with 50 minutes DHCA was determined from only 2
strokes (of only 12 patients who had required 50 minutes
of DHCA). Thus, the 50-minute threshold should best be
‘‘taken with a grain of salt.’’ Also, 1 of these strokes was
embolic and, thus, not directly attributable to the method
of brain protection. One of these patients had undergone
previous heart transplantation and was hemodynamically
unstable perioperatively, and the other had developed
intraoperative aortic dissection during replacement surgery
for an ascending and arch aneurysm. The other 10 patients
with 50 minutes of DHCA developed no cerebral
problems or complications.ery c September 2014
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cutoff point, below which DHCA is invariably safe, the
results of the present study have provided evidence that
even longer times of up to 50 minutes can be considered
quite safe. We believe that the present study adds an
important additional 10-minute ‘‘cushion period’’ in the
armamentarium of the surgeon that allows extra time for
more complex procedures should extended periods of
circulatory arrest be needed.
Neurocognitive Recovery
Several studies that evaluated the postoperative
neurocognitive function of patients undergoing surgery
with DHCA reported its negative effect on neurologic
function.16,27-29 In contrast, Svensson and colleagues30
found DHCA to be the superior method for preserving
neurocognitive function. Our group previously reported
that in patients with high cognitive needs for their profes-
sions (ie, physicians, lawyers, administrators, accountants),
DHCA had no effect on their reported cognition or work
performance postoperatively.31 Furthermore, in a study
recently published by our group, we were able to show
that the overall neurocognitive function was well preserved
among patients operated under DHCA and was not different
between patients undergoing surgery with and without
DHCA.32 One of the recent studies of neurocognitive
function from the Mount Sinai group revealed that DHCA
(14-40 minutes) or isolated CPB (70-369 minutes) did not
have an adverse effect on postoperative cognitive function.
However, selective cerebral perfusion (range, 39-83
minutes) was a significant predictor of a decline in
performance on memory and language tests.33
Comparison of DHCA and Other Cerebral
Protection Techniques
Our group has previously published several reports with a
detailed literature review comparing various cerebral
protection techniques.6,17,25 It is clear that all 3 techniques
currently in use (straight DHCA, ACP, and RCP) are
viable options for cerebral protection during aortic arch
surgery, and their use is largely dependent on institutional
and individual surgeon preference. However, each
technique has advantages and limitations.25 RCP can be
helpful in flushing the cerebral vasculature of toxic meta-
bolic products and embolic debris; however, this technique
has become increasingly less popular because not much
oxygen actually reaches the neuronal tissue.34 ACP is the
most physiologic technique. Because it delivers oxygen-
rich blood to the brain, ACP currently ranks as themost pop-
ular and widespread technique. ACP is very useful when
>50 minutes might be needed to complete the procedure.
However, uncertainties remain regarding the number of ves-
sels that need to be perfused and the appropriate flow rates to
deliver enough oxygen but not cause cerebral edema.35The Journal of Thoracic and CaAll these factors make the simplicity and elegance of
straight DHCA especially appealing. According to a recent
poll reported by Ziganshin,36 48% of experts use straight
DHCA. The data from the present study has provided justi-
fication for such continued use of DHCA. No manipulation
of the head vessels is required, no cerebral edema occurs,
and a branched perfusion system is not needed with
DHCA. These characteristics are especially useful in the
setting of emergency procedures, such as acute aortic
dissection, that can spare little time for setting up adjunctive
perfusion. DHCA provides a clean, bloodless operative
field, with no intrusive clamps or adjunctive perfusion
cannulas.Study Limitations
One of the limitations of the present study was its
retrospective nature. That we identified only 23 patients
with any major adverse outcomes (ie, early mortality,
stroke, seizures, and acute renal failure) permitted us
statistically to use only 2 or 3 variables to establish
associations on multivariable analysis. A comparatively
low number of patients requiring >40 minutes and an
even lower number of patients requiring>50 minutes of
DHCA was another limitation of the present study. Yet
another limitation of the study was that it was center
and surgeon specific, and the results might be difficult to
replicate in a different setting.CONCLUSIONS
Straight DHCA is a safe and effective technique of
cerebral protection for most interventions involving the
aortic arch. Hemiarch operations and straightforward total
arch operations that can safely be completed within 40 to
50 minutes of DHCA are especially well suited to straight
DHCA.We recommend DHCA as the first choice technique
of cerebral protection. Although neither DHCA, RCP, nor
ACP has unequivocally shown significant superior over
the others, the results of the present study have provided
evidence that straight DHCA is at least not inferior to
other neuroprotection strategies and can produce excellent
clinical results.References
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Dr Joseph D. Schmoker (Burlington, Vt). Congratulations on
your outstanding results.
Both the mortality rate of 2.4% and the stroke rate of 1.6% in
this large series of patients over the span of 11 years is highly
commendable. You have improved on your previous stroke rate
of 3.1% reported in 2007. These results helped to reinforce a
role for DHCA when performed properly in the treatment of
noncomplex aortic arch pathology when the circulatory arrest
times are<40 minutes, such as was the case in your series and
inclusive of almost 90% of your patients.
However, the data interpretation becomes more problematic
when analyzing the risk of stroke with longer arrest times. In
your previous series, the stroke rate was 13% if the arrest
time was >40 minutes. In the present study, the mean arrest
time for those patients with stroke was 39 minutes, and the
stroke rate increased to 17% when the arrest time was
>50 minutes. From these aggregate data, evidence exists of a
strong trend toward an increased stroke risk after 40 minutes
with DHCA alone.
I take issue with your interpretation that your embolic strokes
had no association with the circulatory arrest duration. Emboli
superimposed on cold ischemia can add insult to the vulnerable
at-risk tissue, the penumbra, and certainly could contribute to a
more profound deficit. In that fashion, the circulatory arrest time
could have an effect on stroke severity related to emboli.
This brings me to 3 questions, and we will take each
individually. The definition of stroke used in this project (ie, the
requirement for both a clinical deficit and positive imaging study
findings) might serve to underreport the incidence if careful
imaging was not performed in all patients with a deficit, which
would include those with seizures and other more prolonged
temporary neurologic dysfunction.ery c September 2014
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permanent deficit alone, whether a focal deficit or a generalized
deficit such as a gait disturbance or Parkinsonism, or any deficit,
however, brief or extended associated with a positive finding on
imaging.
Did you follow this definition, and, if so, did all patients with
extended temporary neurologic dysfunction or seizures undergo
appropriate imaging?
Dr Ziganshin. Thank you very much for your comments and
questions, Dr Schmoker.
In terms of the first question, we used the following definition of
stroke: a clinically and radiologically (computed tomography [CT]
or magnetic resonance imaging) recognized neurologic deficit. All
patients with a persisting deficit underwent CT, and, if the deficit
persisted and the CT findings were negative, they underwent
magnetic resonance imaging.
In terms of temporary and neurologic deficits—we found these
very difficult to classify and detect because, in our experience,
most patients who could potentially be considered as having
temporary neurologic deficits had confusion as their postoperative
complication.
Confusion, as we know, can occur not only after procedures
involving DHCA, but also any other procedures requiring
cardiopulmonary bypass.
If the neurologic deficits persisted in these patients, they
subsequently underwent imaging studies. However, in our study,
all patients classified as not having a stroke were discharged
home without any neurologic deficits whatsoever.
Dr Schmoker. Thank you. You also answered my second
question regarding the insensitivity of CT for embolic or ischemic
stroke early after surgery and the need for follow-up with magnetic
resonance imaging.
My last question pertains to a concern about peripheral
cannulation and retrograde perfusion in patients with risk
factors for atheroma; 80% of your patients were perfused from
the groin. Although you engaged more central perfusion if
evidence was found of atheroma in the descending thoracic aorta
on imaging, it appears that no policy was in place to obtain
abdominal imaging preoperatively. It is possible that the embolic
strokes could have occurred from undetected debris dislodged
from the atheromatous abdominal or iliofemoral systems by
retrograde perfusion.
Knowing that 5 patients had embolic stroke and 3 patients had
hypoperfusion as their stroke etiology, what was the breakdown
between the central and peripheral cannulation in these 2 groups?
Thank you.
Dr Ziganshin. Thank you very much for your question,
Dr Schmoker.
That is a very important point, and we do acknowledge that we
could not safely state that in all patients abdominal imaging was
performed.
However, it is a policy at our institution to perform abdominal
CT imaging for all patients undergoing elective surgery.
Of course, in an emergency setting, it is not possible to obtain a
CT image, and then we have to rely on intraoperative transesopha-
geal echocardiography to detect atheromatous debris.
However, as a second point, in our experience, it is very rare to
have severe atherosclerotic disease in the abdominal aorta and toThe Journal of Thoracic and Cahave absolutely no involvement of the descending aorta. That is
why we believe our approach is safe.
In terms of the breakdown between central and peripheral
cannulation, I have it here on the slide. Ten percent of the patients
in the entire study cohort received right axillary cannulation, 9.4%
received distal arch cannulation, and only 1% received innominate
artery cannulation. All other patients were perfused via the
femoral artery.
In terms of the patients with embolic strokes: the total was 5, 2
had been cannulated via the femoral artery, 2 had undergone distal
arch cannulation, and 1 patient had undergone right axillary
cannulation. Thus, we can see that retrograde flow was only
used in 2 of these patients with embolic stroke.
Dr Schmoker. Thank you.
Dr Joseph S. Coselli (Houston, Tex). Quick question. Did you
have any deaths in your series that were unable to be evaluated
neurologically, and if so, how did you include those in your
analysis?
Dr Ziganshin. We had 1 case of an intraoperative death.
That was a case of an acute type A dissection, and we were unable
to include that patient in our neurologic analysis; however, that
patient was included in the study as an early death.
Dr Scott A. LeMaire (Houston, Tex). The rewarming strategy
can also influence the incidence of neurologic complications.
Would you tell us about your rewarming strategy, particularly
because you used bladder temperatures. What temperature do
you rewarm to? What is the rate of rewarming?
Dr Ziganshin. The rewarming time is usually about 1 hour. We
do not hurry with rewarming. We take as much time as needed,
especially for patients who are obese or overweight. Such cases
require a significant amount of rewarming time. The difference
in temperature of the perfusate is about 10C always, and we
rewarm until about 34C.
Dr LeMaire. Thirty-four, okay. Thank you.
Dr Ourania Preventza (Houston, Tex). Congratulations for
this excellent study. I would like to ask you, what was your
transfusion rate during the aortic arch surgery?
Dr Preventza. All your cases were performed with straight
DHCA. What was your transfusion rate during the aortic arch
surgery?
Dr Ziganshin.We did not look at this parameter specifically in
light of this study, but from our clinical experience, the transfusion
rate for our aortic interventions was no different than that for any
other cardiac procedures performed at our center.
The re-exploration rate for bleeding was 4.5%.
Dr Preventza. Okay. Thank you.
Dr Burkhart Zipfel (Berlin, Germany). I have a question on
your double artery island technique.
Dr Zipfel. How do you handle the left subclavian artery then,
do you just occlude it?
Dr Ziganshin. The technique illustrated on the slide is the
preferred technique that we use at our institution. The elephant
trunk graft is usually placed, and we leave it relatively long
if we anticipate a second-stage procedure. If a second-stage
procedure is needed, that means that the descending aorta is
relatively dilated, and there is enough room for retrograde flow
to the left subclavian artery. In our experience, we have not seen
complications related to the left subclavian artery.rdiovascular Surgery c Volume 148, Number 3 899
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procedure to determine whether the flow to the left subclavian
artery is compromised. Because the left subclavian artery has a
radial catheter in it, we check to see whether the central pressure900 The Journal of Thoracic and Cardiovascular Surgis different from the pressure in the radial artery. If it is, we perform
a bypass during the first-stage procedure. If it is not, we leave the
left subclavian artery and manage it during the second-stage
procedure, when this is much easier and safer to do.ery c September 2014
